Emerging evidence indicates that
2,2',4,4'-tetrabromodiphenyl ether (BDE-47) induces liver injury through enhanced ROS production and lymphocytic infiltration, which may promote a liver inflammatory response.
Antioxidants have been reported to attenuate the cellular toxicity associated with
polybrominated diphenyl ethers (
PBDEs). In this study, we investigated the effect of
troxerutin, a trihydroxyethylated derivative of the natural
bioflavonoid rutin, on BDE-47-induced liver
inflammation and explored the potential mechanisms underlying this effect. Our results showed that
NAD(+)-depletion was involved in the oxidative stress-mediated liver injury in a
BDE-47 treated mouse model, which was confirmed by
Vitamin E treatment. Furthermore, our data revealed that
troxerutin effectively alleviated liver
inflammation by mitigating oxidative stress-mediated
NAD(+)-depletion in
BDE-47 treated mice. Consequently,
troxerutin remarkably restored
SirT1 protein expression and activity in the livers of BDE-47-treated mice. Mechanistically,
troxerutin dramatically repressed the nuclear translocation of NF-κB p65 and the acetylation of NF-κB p65 (Lys 310) and
Histone H3 (Lys9) to abate the transcription of inflammatory genes in BDE-47-treated mouse livers. These inhibitory effects of
troxerutin were markedly blunted by EX527 (
SirT1 inhibitor) treatment. This study provides novel mechanistic insights into the toxicity of
BDE-47 and indicates that
troxerutin might be used in the prevention and
therapy of BDE-47-induced hepatotoxicity.